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Abstract
Five percent of the 1.8 million patients diagnosed with cancer in the United States (US)
enroll annually in a clinical trial (American Cancer Society, 2021; Institute of Medicine
Committee on Cancer Clinical Trials; National Cancer Institute Cooperative Group Program,
2010). Flawed research consent practices are detrimental to patient safety and costly to the US
Healthcare system (Eisenberg et al., 2012; Unger et al., 2019). Well trained nurses are imperative
to conducting rigorous, reproducible, and quality research (Brandt et al., 2011). Programs
designed to educate nurses on how to implement comprehensive communication strategies
confidently during the Cancer Clinical Trials (CCT) consent process remain scarce (Nusbaum et
al, 2019; Purdom et al., 2017). The purpose of this quality improvement project was to develop,
implement, and evaluate the effects of an evidenced-based education program on nurse
confidence with use of the teach-back method during the CCT consent process. An evidenced
based education program was developed. It was implemented as a synchronous webinar to
members of the International Association of Clinical Research Nurses. Pre and posttest program
surveys measuring confidence levels were disseminated. There was on overall increase in postsurvey responses suggesting an improvement in confidence levels with use of the teach-back
method during the CCT IC process. Further study can explore if patient understanding of CCTs
during the IC process is developed proportionally to levels of nurse confidence with use of the
teach-back method.
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Chapter 1
Introduction
Informed Consent in Cancer Clinical Trials
1.8 million adults are newly diagnosed with cancer every year in the US and around five
percent of those enroll in cancer clinical trials (CCT) (American Cancer Society [ACS], 2021;
Institute of Medicine Committee on Cancer Clinical Trials; National Cancer Institute [NCI]
Cooperative Group Program, 2010). International and national laws, regulations, and guidelines
serve as a reference for the US Office of Human Research Protection (OHRP) to govern the
scientific community and frame their policies for human subject protection in research (Belmont
Report, 1979; Declaration of Helsinki, 1964; International Council for Harmonisation [ICH],
2016; Nuremberg Code, 1947; World Health Organization Good Clinical Practice [GCP] 1996).
To modernize and improve the US research enterprise, efforts were made through funding from
the National Research Act of 1974 to create The National Commission for the Protection of
Human Subjects of Biomedical and Behavioral Research that formed the Federal Policy for the
Protection of Human Subjects, or the “Common Rule” in 1991 and revised in 2017, and the
Health Insurance Portability and Accountability Act of 1996. These laws, regulations, and
guidelines are enforced by the US Department of Health and Human Services (HHS), the 14
other agencies which govern the conduct of research operations in the US, and by the US Food
and Drug Administration (FDA) [Bierer et al., 2017].
To contrast the breakthroughs made over the past 30 years in cancer treatment efficacy,
the level of patient understanding during the IC remains unchanged (NCI, 2021). An example of
“responsible conduct of research involving human subjects,” is obtaining Informed consent (IC)
prior to clinical trial participation with “sufficient opportunity for patients to consider whether or
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not to participate, to understand the potential risk, benefits or alternatives, and that minimize the
possibility of coercion or undue influence” (FDA, CFR Title 21, Section 50, 2020; ICH, 2016).
Having well trained nurses is imperative to conducting rigorous, reproducible, and quality
research (Brandt et al., 2011). Evidence-based training programs designed to educate nurses on
the ways to implement clear, comprehensive, and engaging communication methods to improve
patient understanding during the CCT consent process remain limited (American Nurses
Association [ANA] & International Association of Clinical Research Nurses [IACRN], 2015;
Bevans et al., 2012; Castro et al., 2011; Oncology Nursing Society [ONS], 2016).
Problem Statement
Barriers to patient understanding during the CCT IC process have persisted for over 50
years (Krieger et al. 2015; Nishimura et al., 2013; Pentz et al., 2012; Schumacher et al., 2017).
Evidenced-based training programs designed to educate nurses on the ways to implement clear,
comprehensive, and engaging communication methods during the consent process remain
limited (Glaser et al., 2015; Kass et al., 2015). Teach-back is an evidence-based, feasible, and
affordable method of practice to use during the CCT IC process for real-time assessments of
patient understanding and to test how well nurses explain complex concepts (Anderson et al.,
2020; Dinh et al., 2016; Lentz et al., 2014; Talveski et al., 2020). A nurse’s confidence with the
use of the teach-back method during the consent process could conceivably develop patient
understanding of CCTs and promote safety. The author of this project developed, implemented,
and evaluated the effects of an evidenced-based education program on nurse confidence with use
of the teach-back method during the CCT consent process.
Significance of Addressing the Problem
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Flawed research consent practices are detrimental to patient safety and costly to the US
Healthcare system (Unger et al., 2019). How to best support the necessary infrastruture and fund
one of the world’s most expensive and least efficent research systems has become a national
concern (Eisenberg, et al., 2012). US Food and Drug Administration warning letters issued to
healthcare organizations demonstrate investigator failures to ensure understanding, to inform on
research terms, the procedures, and treatment goals during the consent process (IMARC, 2019).
Moreover, levels of comprehension and retention, and differences in language contribute to
unrealistic expectations of benefits for potential participants in CCTs (Godskesen et al., 2013;
Hillyer et al., 2020; Kao et al., 2017; Pentz et al., 2012). Patients must be considered competent,
should have the opportunity to be an informed voluntary participant with discussion of the
confidential nature of the decision, and undergo a content comprehension assessment by the
person who is responsible for obtaining consent (NCI, 2020). Patients should be advised to read
the entire form before consenting to participate and there should be a review of the reasonable
alternatives to the proposed intervention and the relevant risks, benefits, and uncertainties related
to each alternative including compensation, medical treatment in the event of injury, and whom
to contact about the research (NCI, 2020). When fully informed, the goal of research will never
sacrifice the rights, interests, and autonomy for humans participating as subjects in research.
During the consent process, teach-back is a communication method which incorporates
summary and review of topics to ensure patient understanding of CCTs, and to promote their
safety (Agency for Healthcare and Research Quality [AHRQ], 2015; Fidyk et al., 2014). When
use of the teach-back method was implemented into nursing practice, disease-specific
knowledge, treatment adherence, and self-efficacy improved by 82% for patients diagnosed with
cancer (Anderson et al., 2020; Krieger et al., 2015; Lentz et al., 2014; Nishimura, et al., 2013;
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Talveski et al., 2020). Competency for the use of the teach-back method is acknowledged in the
Scope and Standards of Practice for Research Nurses and in the Oncology Clinical Trials Nurse
Competencies and Framework, but evidence-based training programs used to reinforce the
practice remain limited (ANA and IACRN, 2016; Bevans et al., 2012; Castro et al., 2011; ONS,
2016; Purdom et al., 2017).
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Chapter 2
Review of the Literature
Literature was reviewed and evaluated to appraise the evidence to support the question
“Does an evidence based education program increase nurse confidence with the use of the teachback method during the CCT consent process?” A summary of main findings and synthesis of
evidence offers implications for practice. Three electronic databases Ovid MEDLINE,
Cumulative Index of Nursing and Allied Health Literature, Pub Med MEDLINE, and ancestry
searches from the reference lists of the Scope and Standards of Practice for Clinical Research
Nurses (ANA & IACRN, 2016) and Manual for Clinical Trials Nursing (Klimaszewski et.al,
2016) were used to identify articles published in English from 1990-2021. The process for
identifying articles is shown using the Preferred Reporting Items for Systematic Reviews and
Meta-Analysis (PRISMA) flowchart (Appendix A). In total, 45 articles were used for this review
of literature. Based on “Johns Hopkins Nursing Evidence-Based Practice: Model and
Guidelines” the “Evidence Level and Quality Guide” tool, this author rated the body of evidence
as level “III” which is equal distribution between “good quality” and “bad quality.” Keyword
search terms included: clinical research nursing, cancer clinical trial nurse, informed consent,
teach-back, patient understanding, and cancer clinical trials. A matrix was developed to
organize extracted information on topics related to IC, CCTs, CCTNs, and teach-back (Appendix
B). Results focus on the barriers and facilitators to patient understanding of IC in CCTs, the
nurse’s role in and confidence level with consent practices, and implementation of the teach-back
method into practice.
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Cancer Clinical Trials
Treatment decisions in cancer care are influenced by structural, clinical, physician, and
patient associated barriers (Unger et al., 2019). The National Cancer Act of 1971 authorized the
NCI, the federal government’s principal agency for cancer research and training, to coordinate
and maintain a national infrastructure of hospitals that “meet rigorous standards for
transdisciplinary, state of the art research focused on developing new and better approaches to
preventing, diagnosing, and treating cancer” (NCI, 2021). NCI centers disseminate evidencebased findings into their local communities with personalized programs, services, and trials that
match the needs of the populations served (Eisenberg et al., 2012; NCI, 2021). CCTs start with a
hypothesis based on clinical expertise, collaboration, review of literature, and involve phases
(Curigliano et al., 2016). The design and phase of the trial is determined by the hypothesis of the
investigator and goals are aimed at an improvement in the prevention, diagnosis, and treatment
of cancer (Nathe & Krakow, 2019; Pentz et al., 2012). Considered the gold standard of design,
randomized controlled trials provide scientific characterization of therapeutic interventions by
limiting bias, and overall survival is the primary endpoint studied (Fiteni et al., 2014). CCTs
determine drug, vaccine, and medical intervention safety and efficacy, modify existing treatment
standards, and evaluate patients diagnosed with cancer in real-world settings (Miller et al., 2013;
Unger et al., 2021). The bio-marker driven therapies, the field of immunology, and how to
expedite treatment delivery to patients influenced the FDA to establish the Oncology Center of
Excellence (Kurtin & Taher, 2020). To streamline the development of cancer therapies, these
efforts utilize an accelerated pathway to measure efficacy through biomarkers, objective/overall
response, and clinical benefit (Mayawala et al., 2017).
Nurse Role in Informed Consent
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Patients develop a greater understanding when nurses are incorporated into the consent
visit (Barrett, 2005; Joffe et al., 2001a). Having well trained nurses is imperative to conducting
rigorous, reproducible, and quality research (Brandt et al., 2011). In a study by Cantini, & Ells
(2007) over half of the nurses (38, 58.5%) reported having no job description when hired and
developed the competence to perform consent by “on the job training.” Nurses view their role
during IC as fundamental to GCP and patient safety but evidence-based training programs on
how to implement such skills in clinical research settings are scarce (Forbes and Phillips, 2020;
Kunhunny & Salmon, 2017;). In 2004, Ehrenberger and Lillington developed the first validated
role delineation tool named the Clinical Trial Nurse Questionnaire (CTNQ). This role delineation
tool provides guidance and competency assessment measures for a nurse’s scope of practice in
clinical research settings (Bevans et al., 2012; Castro et al., 2011). In 2016, the ANA and IACRN
published the Scope and Standards of Practice defining five Domains of Practice for Clinical
Research Nursing (CRN) and 52 associated activities including IC. Further, the ONS (2016)
Competency Model and Framework defines skills nurses must demonstrate to perform initial and
ongoing IC. Evidence-based education and skill training programs help nurses translate what
they learn into practice (Nusbaum et al., 2019: Purdom et al., 2017). Quality improvement
projects implemented in the US have increased consent training opportunities for nurses and
results revealed increased mean confidence levels with use of the teach-back method because
they (Herena, et al., 2018; Regan, 2018; Showalter et al., 2018).
Patient Understanding During Informed Consent in Cancer Clinical Trials
Patient understanding of IC has not changed over the past three decades, and importantly,
it mediates the relationship between a patient’s self-efficacy and decisional conflict to participate
in CCTs (p=0.003) [Tam et al., 2015]. Factors that contribute to a patient’s level of CCT
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understanding during IC include innovations in clinical trial desisgn, changes in the setting of
clinical reseach delivery, first in human studies, an increasing number of procedures per
protocol, readability, and length of consent forms (Godskesen et al., 2013). Further, many
patients with low levels of health literacy are unaware that alternative treatments exist and
perceive clinical trial participation as personal medical care instead of research (Pentz et al.,
2012; Schumacher et., al, 2017). The Institute of Medicine (2010) defines Health Literacy as:
“The degree to which individuals have the capacity to obtain, process, and understand basic
health information and services.’’ Health literacy is fundamental to informed decision-making
and is influenced by individual, cultural, social, and political factors (Fidyk et al., 2014; Speros,
2011). The patient may develop a lower level of comprehension which compromises their safety
when there is a breakdown in communication between them and the clinical research team
(Miller et al., 2013; Hillyer et al., 2020).

Methods that improve the quality of communication during IC include extended contact
with healthcare professionals and discussion with a question and answer session (AHRQ, 2020).
They significantly increase comprehension of a patient’s treatment options, the risks and
discomforts associated with participation, the research design, and the unproven nature of the
trial (Bergenmar et al., 2014; Kass et al., 2015; Nishimura et al., 2013). The Quality of Informed
Consent Questionnaire (QuIC) is a tool used by researchers to measure a patient’s objective and
subjective understanding, and to assess for adequacy of the CCT IC process (Joffe et al., 2001a;
Joffe et al., 2001b). The QuIC tool was used in four studies for researchers to measure patient
understanding and when compared to standard practice, their comprehension improved by 100%
when teach-back or test/feedback components were implemented into the consent process
(Gillies, et. al., 2018). For patients diagnosed with cancer, teach-back decreases uncertainty
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related to randomization, significantly improves comprehension of disease knowledge (p <
0.001), medication adherence (p < 0.001), and self-efficacy (p = 0.0026) [Dinh, et al., 2016;
Juraskova, et al., 2014; Krieger, et al., 2015].

Use of Teach-back as an Intervention to Improve Patient Understanding
Teach-back is an effective method available for nurses to communicate complex trialspecific information to patients during the consent process (Lentz et al., 2014). Teach-back, a
communication method used for real-time assessment to confirm patient understanding of
complex health concepts, is recognized as one of the 50 essential practices to support patient
outcome improvement by the National Quality Forum (Anderson et al., 2020; AHRQ, 2020;
Regan, 2018; Speros, 2011). The use of the teach-back method is effective across a wide range
of settings, populations, and outcome measures and is an affordable, and feasible technique
which promotes health literacy and ensures patient understanding during the CCT IC process
(Glaser et al., 2020; Kass et al., 2015; Krieger et al., 2015; Schumacher, et al., 2017; Talveski et
al., 2020). Use of the teach-back method helps nurses facilitate the process and helps them
consider the patients’ psychosocial situation, family support, and appropriate timing of consent
(Nishimura, et al., 2013). An observation tool called “the 5Ts for Teach-Back,” proved useful for
training, and implementation of the teach-back method (Anderson et al., 2020). A nurse must
choose the pertinent information for the patient to comprehend, use tools when teaching,
verbalize that material presented to the patient is obscure, explain that the clinician is the one
being tested for how well the concepts are explained, encourage the patient to give an
explanation of concepts, and repeat parts of the discussion if needed when implementing teachback into practice (Anderson et al., 2020).
Implications for Practice
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Nurses should be sensitive to factors which influence health literacy and must make
greater efforts to use clear, comprehensive, and engaging communication methods to help
patients make informed healthcare decisions that are consistent with their goals and values
during the consent process (Anderson et al., 2020; Bergenmar et al., 2014; Fidyk, et al., 2014;
Kass et al., 2015; Pentz et al., 2012; Talveski et al., 2020). Nurses must personalize the consent
discussion to meet the individual needs of a patient, provide adequate time for questions, and
use methods that confirm understanding (AHRQ, 2020; Glaser et al., 2020; Speros, 2011). As
shifts in funding occur, and as the volume, complexity, and regulations of clinical trials increase,
use of the teach-back method has potential to affect a great number of patients (Getz & Campo,
2018; Krieger et al., 2015). While few strategies exist to support the translation of the teach-back
method into clinical practice, an evidence-based education program may improve nurse
confidence with its use during the CCT consent process (Dinh et al., 2016).

Project Management Framework
Kurt Lewin’s Change Management Model (1947) was chosen to understand how change
occurs and it is segmented in to three stages: Unfreeze, Move, and Refreeze (Lewin, 1947;
Appendix C). Lewin (1947) postulated that individuals need to feel the necessity for change and
that successful implementation is created by sensitizing the change process, strengthening all
changing forces, and reinforcing the newly achieved change (Lewin 1947). According to Lewin
(1947), driving forces originate in ambitions, goals, needs and fears whereas restraining forces
oppose driving forces. The first stage in Lewin’s Change Management Model (1947) is
Unfreezing, which began when the project author recognized the need for nurses to have a
standardized process of consent in CCT. When questioned, members of IACRN reported no
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standardization of consenting practices, little formalized trainings on the topic, and varying
levels of confidence with use of the teach-back method during the process. A stakeholder
analysis was conducted. It revealed the need for a project which increases educational
opportunities for clinical research nurses. The second stage in Lewin’s Change Management
Model (1947) is Move and is when the construction and implementation of the DNP project
commenced. In this stage, nurses resolve their uncertainty about the need for change of IC
processes and begin to accept new ways of practice. The third stage in Lewin’s Change
Management Model (1947) is Refreeze. If the project was successful, the nurses will have more
confidence with use of the teach-back method during the IC process.

Organizational Description and Assessment
Organizational Description
The International Association of Clinical Research Nurses (IACRN) is a professional
nursing organization. Established in 2009, IACRN’s purpose and mission is to define, validate,
and advance clinical research nursing as a specialty across all settings through research,
education, collaboration, and dissemination of best practices (IACRN, 2012). It supports the
professional development of nurses who directly or indirectly influence the care of clinical
research patients and defines clinical research nursing as, “the specialized practice of
professional nursing focused on maintaining equilibrium between care of the research participant
and fidelity to the research protocol and incorporates study management throughout a variety of
roles, and practice settings’’ (IACRN, 2012). The vision of IACRN is: “Enhancing clinical
research quality and safety through specialized nursing practice” (IACRN, n.d.).
Organizational Assessment
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IACRNs has a board of directors and officer positions. They include a president,
president-elect, secretary and treasurer who are elected for two year terms (IACRN, 2021).
General membership meetings are held at a minimum of one time per year (IACRN, n.d.).
IACRN has outlined its strategic initiatives for the years 2020-2024. Initiatives are to grow the
professional nursing organization, advance organizational infrastructure, define clinical research
nursing as a specialty practice, and to support the professional development of clinical research
nurses consistent with its mission and vision (IACRN, n.d.). Particularly, IACRN intends to
increase brand awareness, offer live streaming of webinars and presentations, and support
organization driven evidence based practice with research nurses globally (IACRN, n.d.).
IACRN has a research committee and its purpose is to uphold the mission and vision of the
organization through promotion of evidence based practice that drives excellence in clinical
research nursing by supporting the research needs of its members and advancing clinical research
nursing science (IACRN, n.d.).
SWOT Analysis
A SWOT analysis was conducted to identify the strengths, weaknesses, opportunities,
and threats to this DNP project. The strengths and opportunities identified for this project
outweighed the potential weaknesses and threats (Appendix D).
Strengths: Strengths of this project included access to abundant teach-back resources. The
project was congruent with the vision and mission of IACRN. It operationalized ICH-GCP for
nurses and reinforced how to skillfully communicate alternative treatments, the relevant risks,
benefits, and uncertainties of CCT participation to patients. This project empowers nurses to
provide opportunities for patients to clarify misconceptions in real-time during IC process.
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Weaknesses: Weaknesses of this project included exclusivity of the education program to
IACRN members only which resulted in a reduced amount of nurses who participated in the
program. The event was virtual and it made it more difficult for the project author to develop
meaningful connections with the attendees. This program was only advertised to IACRN
members for three weeks before implementation.
Opportunities: This project increased nurse confidence with use of the teach-back method
during the CCT IC process. This education program may become part of a training session
offered by IACRN on a yearly basis. This education program may be replicated at the project
author’s workplace an in similar CCT settings.
Threats: The program was only presented once. Despite evidenced-based training, nurses may
refuse to use the teach-back method in their consent practices. Some nurses may have missed the
opportunity to attend the live webinar due to prior commitments, or time constraints related to
their current workload. Some nurses may have been unaware of the opportunity.
Project Goal and Aims
Goal
The purpose of this project was to develop, implement, and evaluate the effects of an
evidence-based education program on nurse confidence with use of the teach-back method
during the CCT consent process.
Aims
The aims for this project were:
1. To develop an evidence-based education program on use of the teach-back method
during the CCT consent process.
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2. To implement, and evaluate the effects of an education program on nurse confidence
with use of the teach-back method during the CCT consent process.
3. To make recommendations for sustainability, scalability, and dissemination of the
evidence-based education program within the current environment and to provide
recommendations for piloting the practice in other settings.
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Chapter 3
Methods
Overview of Methods
The purpose of this DNP project was to develop, implement, and evaluate the effects of
an education program on nurse confidence with use of the teach-back during the CCT consent
process. Pre and posttest evaluation survey results were analyzed to evaluate if nurse confidence
with use of the teach-back method improved after implementation of the education program.
Finally, after careful evaluation of results, the author made recommendations for sustainability,
scalability, and dissemination of the project.
The project aims were as follows:
Aim 1: Develop an evidence-based education program on the use of the teach-back
method during the CCT consent process.
Methods
This evidence-based education program was developed to inform nurses on the use of the
teach-back method during the CCT consent process. Through the synthesis of literature
organized in the evidence matrix, the teach-back method was identified as an evidence-based,
feasible, and cost-effective method of practice that provides real-time assessments of patient
understanding, tests how well nurses explain complex concepts, and promotes safety. Additional
guidance was obtained from the AHRQ toolkit, and from internal and external project advisors
(Abrams, et al., 2012; Shoemaker & Brach, 2017).
Specifically, the objectives for this evidence-based education program were:
1. The participant will be able to identify factors that influence patient understanding
and promote learning.
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2. The participant will be able to define health literacy.
3. The participant will be able to understand and describe steps of the teach-back
method.
4. The participant will be able to describe the role and value of the teach-back method.
5. The participant will be able to identify strategies to facilitate the use of teach-back
into their oncology clinical trial consenting processes
Teaching Plan. Multimodality teaching and learning strategies were chosen to reinforce
comprehension of teach-back principles (Abrams, et al., 2012; Anderson et al., 2020; Lentz et
al., 2014; Shoemaker & Brach, 2017; Talevski et al, 2020). A formalized training program is an
existing strategy to support the translation of teach-back into clinical practice (Dinh et al., 2016;
Talevski et al, 2020). A teaching plan was developed to help the project author organize and
formalize the important elements of the evidence-based education program (Appendix E). The
teaching plan includes methods, objectives, and program content, and the slide deck lecture that
includes interactive knowledge checks, and a case study presentation (Appendix F). For quality
improvement purposes, the project author gave mock presentations with external project advisors
until the program was implemented.
Tools. The Teach-back method toolkit was created by key opinion leaders of patient
teaching and learning from Picker Institute, Des Moines University, the IOWA Health system,
and Health Literacy Iowa (Abrams et al., 2012). Some topics and tools chosen for inclusion into
the education program were found in the AHRQ teach-back toolkit. Permission from the original
authors to use the AHRQ Teach-back toolkit for this project was obtained (Abrams, et al., 2012)
[Appendix G]. The education program slide deck was developed by the project author using
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Microsoft PowerPoint software. The project author presented the education program as a live
webinar which lasted 90 minutes.
Evaluation
The project author identified guiding principles through the synthesis of literature found
in the evidence matrix, the AHRQ toolkit, and consensus among the internal and external project
advisors. Each step of development added to rigor of the work and content validity. Until it was
implemented, external advisors reinforced content of the evidence-based education program and
allowed the project author to review principles of the webinar at regularly scheduled intervals.
Aim 2: Implement and evaluate the effects of an education program on nurse confidence
with the use of the teach-back method during the CCT consent process.
Methods
The purpose of this evidence-based interactive webinar was to implement and evaluate if
nurse confidence with the use of the teach-back method during the CCT consent process
improved. After the project proposal was approved by internal project advisors, an email request
was sent to the IACRN research committee (Appendix H) explaining the purpose of the
education program, length of time for completion, timeline for implementation, a list of the pre
and posttest survey questions, and a PDF of the presentation slide deck. Then, verbal approval
from the research committee chair was obtained. A date for implementation was identified, and
recruitment efforts commenced. IACRN promoted the program in their monthly newsletter that
was sent to their general members. Attendees were required to email the project author in
advance for program registration. Then, they received emails immediately before and after the
program which included pre and posttest evaluation survey links (Appendix I). The post program
email reinforced the content of the program because it included the teach-back toolkit, teach-
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back observational tool, and the project author’s slide deck presentation. Email reminders to
complete the posttest evaluation survey were sent at one and two week intervals.
Instruments. During the program, the nurses were introduced and encouraged to use the
Teach-back Observational Tool as a guide to help them implement the method into the CCT IC
process (Abrams, et al., 2012) [Appendix J]. When nurses previously implemented use of this
tool into cancer settings, patient outcomes improved (Anderson et al., 2020; Fidnyk et al., 2014;
Nusbaum et al., 2017; Talveski et al., 2020). Permission to use the Teach-Back Observational
Tool was obtained from the original authors (Abrams, et al., 2012).
Measures. Pre and posttest evaluation survey questions were based on best available
literature. Completion of the surveys implied consent. Participation was voluntary, answers were
anonymous, and no incentives for the responses were offered. Criteria for participation included
being a registered nurse who is an active member of IACRN. Four of the pre and posttest
evaluation survey questions were used to identify essential elements of teach-back used in
practice and were adopted from the Conviction and Confidence Scale (CCS) found in the AHRQ
teach-back toolkit (Abrams, et al., 2012) [Appendix K]. The CCS questions included two Likert
type, a multiple choice, and a check all that apply which asks nurses to identify essential
elements of teach-back used in their practice (Abrams, et al., 2012). Four demographic questions
were adopted from the CTNQ and permission to use was not required as they are accessible in
the public domain (Bevans et al., 2012; Castro et al., 2011; Ehrenberger & Lillington, 2004;
Purdom et al., 2017).
Tools. This DNP project utilized the Yale Qualtrics tool interface. It is an online tool that
creates, distributes, and analyze survey answered. Both surveys were accessed and tabulated

18

using Qualtrics survey software. It enabled organized management of the data collection and
analysis of the survey responses.
Evaluation
Data were collected, analyzed, and used to identify if nurse confidence and conviction
with the use of the teach-back method during the CCT consent process improved after
implementation of an evidence-based education program. Demographics were used to describe
the population of nurses who participated.
Aim 3: To make recommendations for sustainability and scalability of the education
program within the current environment and to provide recommendations for piloting the
practice in CCT settings.
Recommendations to ensure sustainability:
1. Present the data collected from project to the IACRN research committee
2. Consider revision of the education program after data analysis.
3. Develop a sustainability plan and implement based on IACRN’s needs and the
professional organization’s strategic initiatives.
Recommendations to ensure scalability:
1. Implement a method validation assessment for the nurses who participate in the training.
2. Live stream the webinar multiple times a year to IACRN members. Invite original
participants to attend as “teach-back champions” to share their experiences during the
open dialogue portion of the program.
Recommendations to ensure dissemination:
1. Submit an abstract for consideration to present findings at the annual IACRN Congress.
2. Present the education program to nurses at the project author’s workplace.
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Project Timeline
Aims developed, implemented, and evaluated were used as milestones in the project
timeline. Development of the education program ended in December 2021. Implementation of
the education program was done in January 2022. Evaluation of implementation began in
January 2022 and ended in the final semester of the DNP program. The Gantt chart (Appendix L)
was monitored by the DNP student and internal/external project advisors (Stakeholder analysis
Appendix M). This ensured appropriate progress, and adjustments were made in a timely
manner.
Statement about Human Subjects
While this project is quality improvement in nature, non-research determination by the
Yale University IRB was determined. It was reviewed and met criteria as outlined in 100 CH.9
Clinical Quality Improvement Form (Appendix N). Collection of empirical data through pre and
posttest evaluation surveys maintained nurse confidentiality.
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Chapter 4
Results
After completing the development and implementation portions of the project, the
following section details evaluation of the results. The first aim involved synthesizing the best
evidence to develop a training program delivered by webinar on the use of the teach-back
method during the CCT IC process. The second aim involved implementation and evaluation of
an evidence-based education program. The third aim involved developing a sustainability,
scalability, and dissemination plan for the project.
Aim 1: Develop an evidenced-based education program on the use of the teach-back
method during the CCT consent process.
A review of literature was conducted with results synthesized to guide development of the
education program curriculum on the use of the teach-back method during the CCT process. A
matrix was developed to organize extracted information on topics related to IC, CCTs, CCTNs,
and use of the teach-back method. Results focused on the barriers and facilitators to patient
understanding of IC in CCTs, the nurse’s role in and confidence level with teach-back, and
implementation of the teach-back method into practice. The project author focused on cost
avoidance for patients and staff. A staffing, start up, capital, and operational projected and total
costs analysis was completed for project development, preparation and implementation. The
projected total cost of this DNP project was $3,414 US Dollars.
Implications for Practice
For patients to make informed choices that are consistent with their goals and values,
discussion must be personalized to meet individual needs (Lentz et al., 2014; Juraskova,
2014). Use of the teach-back method has the potential to affect a large number of patients as
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shifts in funding occur in the US, and as the volume of clinical trials, complexity of research
procedures and regulations increase (Krieger et al., 2015). Nurses must be sensitive to factors
which influence a patient’s health literacy and should make efforts to use clear, comprehensive,
and engaging communication methods during the consent process (Anderson et al., 2020;
Bergenmar et al., 2014; Dinh et al., 2016; Fidyk, et al., 2014; Kass et al., 2015). Education and
training programs for nurses centered on teach-back may help them to develop confidence when
performing the IC process (Talveski et al., 2020). Use of the teach-back method helps nurses
facilitate the consent process and helps them consider the appropriate timing of consent, the
patients’ psychosocial situation, and family support (Nusbaum et al., 2019).
Evaluation
The evidence-based education program content was successfully developed for nurses to
learn about the factors that influence patient understanding and promote learning, health literacy,
steps of the teach-back method, the role and value of the teach-back method, and strategies to
facilitate the use of teach-back into their oncology clinical trial consenting processes. Content
was based on results synthesized in the literature review, evidence-based guidelines, and best
practice recommendations from internal and external advisors. The actual total cost of this DNP
project was $235.00 US Dollars. Over 40% of the projected cost was related to the online
platform which was used to administer and collect pre and posttest evaluation survey responses
from the participants. Use by the DNP author was free of charge through the university. Further,
over 50% of the actual total cost was the professional organization membership fee. The
objectives, methods and content of the program followed the format outlined in the teaching
plan.
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Aim 2: To implement and evaluate the effects of an education program on nurse confidence
with the use of the teach-back method during the CCT consent process.
The project author presented a livestreamed Webinar on January 6, 2022 that lasted 90
minutes. Attendance was free of charge for IACRN members. During the session, nurses were
encouraged to participate in three interactive multiple choice knowledge checks. A 30 minutes
dialogue on the use of the teach-back method during the CCT consent process concluded the
presentation. At the end of the program, those who participated in the live webinar were eligible
to participate in a gift card raffle. First names were written on to small strips of paper, placed into
a hat, and one participant was chosen at random by the project author to receive a $100 US
Dollar gift card. However, no incentives were given for survey responses. Survey completion
was based on convenience, was voluntary, and anonymous. A total of 12 participants completed
both the pre and posttest evaluation surveys for the evidence based education program.
Evaluation
Four demographic questions were asked and sample characteristics of participants
were described in table 1. Four pretest and posttest questions were asked to identify essential
elements of teach-back used in practice and were adopted from the Conviction and Confidence
Scale (CCS) found in the AHRQ teach-back toolkit (Abrams, et al., 2012). Participant scores
were reviewed and analyzed. Mean scores were calculated for each item in tables 2 and 3.
Frequency distributions were calculated for each item as shown in tables 4 and 5.
Nurse Demographics
Table 1 presents the demographics of the IACRN members who attended the education
program and participated in the pre and posttest evaluation surveys.
Table 1
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Sample Characteristics of Participants (N= 12)
Characteristic/Question

N

%

Age (years)
18-25
26-35
36-45
46-55
56+

4
2
3
3

33.3%
16.7%
25%
25%

3
8
1

25%
66.67%
8.33%

5
1
1

41.67%
8.33%
8.33%

5

41.67%

4
8

33.33%
66.67%

Highest Nursing Degree
Associate
Bachelors
Masters
Doctorate
Years in clinical trial setting
Less than 1
1-2
3-4
5-6
7+
Have you ever had formalized training
on how to perform IC in CCTs?
Yes
No

This project demonstrates the need for formalized training programs for research nurses
on how to conduct the process of IC in CCTs. Of the 12 active IACRN members that
participated, the highest category of participants was between the ages of 26-35 years (n =4,
33.3%), the majority had a master’s degree in nursing (n =8, 66.67%), most had less than one
year of experience in the clinical trial setting (n =5, 41.67%) or more than 7 years of experience
(n =5, 41.67%) and significant amount (had never had formalized training on how to perform IC
in CCTs n =8, 66.67%).
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Nurse Confidence with Use of Teach-back
Table 2 presents mean scores of pre and posttest program survey evaluation responses for
confidence with use of the teach-back method. The question is measured on a 10-point ordinal
scale ranging from 1 (not confident), to 10 (very confident).
Table 2
Mean scores of “On a scale from 1 to 10, how confident are you in your ability to use teachback? 1- Not at all confident, 10- Very confident”

Question
How
confident
are you in
your ability
to use teachback?

Pretest
(N =12)
Mean

Posttest
(N =12)
Mean

Percent
Increase

6.91

9.91

30%

Pre-test evaluation survey responses revealed that nurses had a lower mean confidence
score before program implementation (M =6.91, SD = 2.28). One nurse was not at all confident 1
(n =1, 8.33%). One nurse had a low level of confidence 4 (n =1, 8.33%), Four nurses had
moderate levels of confidence 6 (n =1, 8.33%), 7 (n = 3, 25%). Six nurses had very high levels of
confidence 8 (n = 4, 33.34%), 9 (n =1, 8.33%), 10 (n =1, 8.33%). Post-test evaluation survey
responses revelated nurses had a higher mean confidence score after program implementation (M
=9.91, SD =0.27). One nurse chose the second highest level of confidence 9 (n =1, 8.33%). The
majority of the nurses were very confident with use of the teach-back method 10 (n =11, 91.67
%)
Importance of Teach-back Use
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Table 3 presents mean scores of the pre and posttest program survey evaluation responses
on conviction for the importance of teach-back use. This question is measured on a 10-point
ordinal scale ranging from 1 (not very important) to 10 (very important).
Table 3
Means scores of pre and posttest survey evaluation survey responses to “On a scale from 1 to
10, how convinced are you that it is important to use teach-back? 1- Not at all important, 10Very important”

Question
How
convinced
are you that
is important
to use teachback?

Pretest
(N =12)
Mean

Posttest
(N =12)
Mean

Percent
Increase

8.25

9.91

16.6%

Pre-test evaluation survey responses revealed that nurses had a lower mean conviction
score before program implementation (M = 8.25, SD= 3.03). Three nurses chose level (3) of
importance and had low conviction (n =3, 24.99%). Nine nurses chose very important (10), and
had the highest levels of conviction (n = 9, 75.01%). Post-test evaluation survey responses
revealed that the nurses had a 16.6% higher mean conviction score after program implementation
(M =9.9, SD =0.27). One nurse chose the second to highest level of importance (9) and had high
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conviction (n =1, 8.33%). The majority of the nurses chose the highest level of conviction (10),
very important ( n =11, 91.7%).
Teach-back Use in Current Practice
Table 4 presents frequency distribution of pre and posttest program evaluation survey
responses and the question asked how long have the participants used teach-back.
Table 4
Frequency distributions of responses for “How often do you ask patients to explain back, in their
own words, what they need to know or do to take care of themselves?”

Pretest
(N =12)

Posttest
(N =12)

I have been doing this
for 6 months or more.

7 (58.33%)

7 (58.33%)

I have been doing this
for less than 6 months.

1 (8.33%)

0 (0%)

I do not do it now, but
plan to do this in the
next month

4 (33.34%)

5 (41.67%)

I do not do it now, but
plan to do this in the
next 2 to 6 months

0 (0%)

0 (0%)

I do not do it now and
do not plan to do this.

0 (0%)

0 (0%)

Question

Pre-test evaluation survey responses revealed that most nurses had been using teach-back
for six months or more (n =7, 58.33%), one nurse had been using teach-back for less than six
months (n =1, 8.33%), and four nurses did not use teach-back but planned to do it in the next
month (n =4, 33.34 %). Posttest evaluation survey responses revealed that the majority of nurses
had been using teach-back for six months or more (n =7, 58.33%), and that five nurses did not
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use teach-back but planned to do it in the next month (n =5, 41.67%). The number of posttest
survey evaluation responses for the question, “I do not do it now, but plan to do this in the next
month,” increased from 33.34 % at baseline by 8.33% up to 41.67 %. None of the posttest
evaluation responses included “ I have been doing this for less than 6 months.”

Effective Elements of Teach-back
Table 5 presents frequency distribution of pre and posttest program evaluation survey
responses for the question on effective elements of teach-back asked to the nurse participants.
This question was a choose all elements that apply with up to 11 possible choices.

Table 5
Frequency distribution of responses to, “Check all the elements of effective teach-back
you have used more than half the time in the past work week.”

Pretest
(N =12)

Posttest
(N =12)

82

87

Use a caring tone of voice and attitude.

8 (9.2%)

8 (9.41%)

Display comfortable body language,
make eye contact, and sit down.
Use plain language.
Ask patients to explain, in their own
words, what they were told.
Use non-shaming, open-ended
questions.
Take responsibility for making sure you
were clear.
Avoid asking questions that can be
answered with a yes or no.
Explain and check again if the patient is
unable to teach back.

10 (11.49 %)

10 (11.49%)

10 (11.49 %)
8 (9.2%)

8 (9.41%)
8 (9.41%)

9 (10.32%)

8 (9.41%)

9 (10.32%)

8 (9.41%)

7 (8.05%)

8 (9.41%)

6 (6.90%)

9 (10.59%)

Element
Number of total responses
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Use reader-friendly print materials to
support learning.
Document use of and patient’s response
to teach-back.
Include family members or caregivers if
they are present.

6 (6.90%)

7 (8.24%)

7 (8.05%)

7 (8.24%)

7 (8.05%)

8 (9.41%)

Nurse participants reported using effective elements of teach-back more than half the
time in the past work week before the program implementation. However, participants reported
using effective elements of teach-back with a higher frequency after program implementation.
The participants (n =12) chose a total of 82 effective teach-back elements in the pretest
evaluation survey. Elements used least frequently included explain and check again if the patient
is unable to teach back (n = 6, 6.90%) and use reader-friendly print materials to support learning
(n = 6, 6.90%). Elements used most frequently included display comfortable body language
make eye contact, and sit down (n =10, 11.49 %), and use plain language (n =10, 11.49 %). The
participants (n =12) chose a total of 87 effective teach-back elements in the posttest evaluation
survey. Elements used least frequently included explain and check again if the patient is unable
to teach back (n = 7, 8.24%) and use reader-friendly print materials to support learning (n = 7,
8.24 %). Elements used most frequently included display comfortable body language, make eye
contact, and sit down (n =10, 11.49 %), and explain and check again if the patient is unable to
teach back. (n =9, 10.59 %).
Aim 3: Make recommendations for sustainability, scalability, and dissemination of the
education program within the current environment and provided recommendations for
piloting the practice in CCT settings.
Implications for Practice
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In 2022, the project author will invite original program participants to share their
experiences. Anecdotal evidence will be collected. They will be asked to describe if use of the
teach-back method during the CCT IC process is feasible in their practice. Program participants
will be encouraged to share if they continue to have confidence with the use of the teach-back
method during the CCT IC process. Further, they will be asked if they have implemented use of
the Teach-back Observational Tool in their teach-back practice.
Evaluation
To ensure sustainability the project author will present an overview including
introduction, objectives/aims, methods, implementation, data analysis, and evaluation of results
in to the IACRN research committee in June 2022. Then, consideration for revision of the will
commence in July 2022. This will be based on IACRN’s strategic initiatives along with revision
recommendations. To ensure scalability recommendations include implementation of a method
validation assessment for future attendees. Based on the sustainability plan, webinars will
commence in the fall of 2022. Webinars will be offered on a quarterly basis. Frequency will
depend on the demand from active IACRN members. Original participants will be invited to
attend as “teach-back champions” and will be encouraged to share their experiences with use of
the method during the CCT IC process. To ensure dissemination, the author will submit project
findings for publication to the Clinical Journal of Oncology Nursing in 2022. Further, the author
will submit the project findings to the 2023 Annual IACRN Congress.
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Chapter 5
Discussion and Conclusion
Discussion
The aim of this quality improvement project was achieved: to develop, implement, and
evaluate the effectiveness of an evidence based education program on nurse confidence with use
of the teach-back method during the CCT IC process. This DNP scholarly project was
affordable, feasible, and nurse confidence improved after implementation of the evidence-based
education program. Primary outcome objectives were analyzed and evaluated: Mean confidence
score with use of the teach-back method before implementation of the program (M = 6.91, SD =
2.28) and mean confidence score with use of the teach-back method after implementation of the
program (M = 9.91, SD = 0.27). Results revealed a 30.00% increase in nurse confidence with use
of the teach-back method after implementation of the evidence-based education program.
Secondary outcome objectives were analyzed and evaluated: Mean conviction score for
importance of teach-back use before program implementation (M = 6.91, SD = 2.28) and
conviction score for importance of teach-back use after program implementation (M =
9.91, SD = 0.27). Results revealed a 16.6% increase in for importance of teach-back use during
the CCT IC process after implementation of the evidence-based education program. While
posttest survey responses from the 12 participants revealed that a majority of nurses had been
using teach-back for six months or more (n =7, 58.33%), the five nurses who had not been using
it before program implementation planned to do so in the next month (n =5, 41.67%). All 12
participants reported using 82 elements of teach-back more than half the time in the past work
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week before the program implementation in the pretest evaluation surveys. However, all 12
participants reported using 87 elements of teach-back, a higher frequency, after program
implementation in the posttest evaluation surveys.
Strengths and Limitations
This project meets the training demands of research nurses and translates the use of the
teach-back method into the consenting process. This project empowered nurses to proficiently
identify components of the IC process for which patients need assistance in understanding. It
reinforced how to skillfully communicate to patients the alternative treatments, the relevant risks,
benefits, and uncertainties of participation in CCTs. Use of the teach-back method allows
patients to clarify misconceptions in real-time and operationalizes GCP. This project supports
attempts to standardize skills of research nurses. There are abundant online teach-back resources
available free of charge for nurses to use. This project was congruent with the vision and mission
of IACRN, which is the only existing international professional organization for clinical research
nurses. While the event was held virtually, the project author developed meaningful connections
with the attendees.
The author initially planned to implement the project in person at a large academic NCICCC. Staffing shortages, turnover, the SARS-CoV-2 pandemic, limited time, and resources
forced the author to find an alternate location for implementation. The design of the project was
changed. This resulted in changes to project implementation, data collection, analysis, and
evaluation of results. The audience size of program was limited to IACRN members only. The
program was only advertised for three weeks before implementation. This may not have been
long enough for nurses to learn about the opportunity. Due to prior commitments or time
constraints related to their current workload, some nurses may have missed the opportunity to
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attend the live webinar. The limited amount of nurses who participated in the program resulted in
a small number of pretest and posttest evaluation survey responses. Lastly, despite evidence
presented in the program, the nurses may refuse to use the teach-back method in their consent
practices.
Implications
Nurses are at the center of patient care, safety, and research (Purdom et al., 2017). Having
well trained nurses is imperative to conducting rigorous, reproducible, and quality research
(Brandt et al., 2011; Fidyk et al., 2014). However, nurse turnover leaves few trained or skilled
research professionals to cover many responsibilities including how to competently obtain IC
(Herena et al., 2018). The more specialized a nurse’s skill set, the more time it takes to develop,
and to replace a role vacancy (Showalter et al., 2017). Turnover is costly, creates a state of
underdevelopment, creates a risk for low levels of participant recruitment, and creates gaps in
enrollments due to protocol suspension (Stroo et al., 2020). Employers save approximately
$40,050 US Dollars for every one research nurse not lost to turnover (Duffield, et al., 2014).
Retention rates may improve and healthcare costs may decrease if nurses are offered training
opportunities, become more confident and knowledgeable of the skills required to perform their
roles in research (Kunhunny & Salmon, 2017). To the authors knowledge this is the fourth
quality improvement project in the US that has increased consent training opportunities and
nurse confidence with use of the teach-back method during the CCT consent process (Herena, et
al., 2018; Regan, 2018; Showalter et al., 2018). These quality improvement projects increased
job satisfaction, and increase retention rates for research nurses. Further, there is no evidence
which suggests that a clinical trial’s enrollment rates are negatively altered by attempts to
improve the consent process (Nishimura et al., 2013). Further, online platforms may be used free
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of charge to replicate similar programs and to increase global sustainability for this method of
training.
Future Work
For patients to make informed decisions, the consent process must be clearly defined and
consistent with their goals and values. Professional development opportunities for research
nurses that support adherence to the principles of ICH-GCP and to the HHS federal regulations
during the consent process foster patient safety (Bierer et al., 2012; Stroo et al., 2020). Further,
these educational opportunities may decrease the financial burden associated with participant
dropout rates. Also, there may be a decrease of bias in treatment efficacy estimates for clinical
trials if patients develop an understanding during the IC process for the level of commitment
needed to attend clinic appointments and to complete medical interventions (Unger et., al, 2021).
Around $20,000 US Dollars can be saved for every one research participant that does not
dropout before collection of primary outcome data (Borno, et al., 2016). To strengthen this
project, further study can explore if patients may begin to understand CCTs proportional to the
level of nurse confidence with use of the teach-back method during the IC process.
Conclusion
Programs designed to educate and train research nurses on the skills needed to
implement clear, comprehensive, and engaging communication methods during the CCT consent
process remain limited (Glaser et al., 2015; Kass et al., 2015). A significant gap exists in
professional development and training opportunities for research nurses. The purpose of this
quality improvement project was to develop, implement, and evaluate the effects of an
evidenced-based education program on nurse confidence with use of the teach-back method
during the CCT consent process. An evidence based education program was developed by the
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utilization of literature pertaining to: Cancer clinical trials, research nurse role in informed
consent, patient understanding during informed consent in cancer clinical trials, and the use of
teach-back as an intervention to improve patient understanding. After program implementation,
the mean score of nurse confidence with use of the teach-back method during the CCT consent
process improved by 30%. To date, the technical and specialized skill set required for clinical
research nursing is not encompassed in undergraduate nursing school curriculum. Employers
must implement consistent evidence-based education programs for new research nurses during
orientation, and increase training opportunities for existing staff. Thus, results present an
argument for expansion of this DNP project to a boarder audience of nurses outside of the
IACRN setting.
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Appendices
Appendix A: PRISMA FLOW DIAGRAM
Figure I - Adapted PRISMA Flow Diagram

Screening

Identification

Records identified through
database searching (n =193)

Additional records identified
through other sources (n = 9)

Records excluded: 40

Records after duplicates removed and
screened by title (n =115)
Records excluded: 11
Non- English articles:3
Conference abstract:
Thesis: 1
Full text unavailable: 3
Not specific to clinical
trials/research: 3
Specific only to clinical
research associate/non
nurses: 1

Abstracts screened (n =73)

Full-text articles assessed for
eligibility (n =64)

Eligibility

Full text articles excluded not
fitting eligibility criteria : 5
Published before 2001: 2
IC Intervention not related to
DNP Project intervention: 3
Topic unrelated to scope of
DNP project: 4

Qualitative and Quantitative Studies
screened for relevance (n =50)

9

Included

Full text articles excluded: 3
Incomplete data reported: 2

Full text articles analyzed to
include in final review (n =45)

Any other articles
excluded (n = 0)

Figure 1 Flow diagram to show number of studies remaining at each stage of literature review. Source: From Moher,
D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group. (2009). Preferred reporting items for systematic
reviews and meta-analyses: The PRISMA statement. PLOS Medicine, 6(7), e1000097.
https://www.doi.org/10.1371/journal.pmed.1000097.
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Appendix B: Evidence Matrix
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Date
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Sample
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Design/Method
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Nishimura., A., Carey,
J., Erwin, P., Tilburt,
J., Murad, M., &
McCormick, J. (2013,
p. 28-40) Improving
understanding in the
research informed
consent process

RCTs testing
interventions to
research IC process

Start of Database
until September
2010 (N =39) RCTs
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Level I A,
Systematic
Review & Metaanalysis

Novel & no
negative
impact on
participant
satisfaction or
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RCTs only

Tam, N., et. al. (2015,
p. 186-198)
Participants’
understanding of
informed consent in
clinical trials over
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trials who understand
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(N =103) studies
135 cohorts of
participants worldwide up to Oct.
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Systematic
review and metaanalysis
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on when a
nurse is
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and the
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level of pt.
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Not able to analyze
the effect on pt.
understanding of IC
or the effect of
understanding in the
presence of a nurse

Unger, J. M., Vaidya,
R., Hershman, D.,
Minasianr, L., &
Fleury, M. (2019, P.
381-402).

Identify barriers to
CCT participation

13 studies with 8883
pts.

Level I A,
Systematic
review and metaanalysis

8 of 13 studies
used were in
the academic
setting. Need
more evidence

Large patient
sample
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Results

Multimedia approaches
non-significant increase
in understanding scores
(SMD 0.30, 95% CI, 0.23 to 0.84), Extended
discussion, with
significant increase
(SMD 0.53, 95% CI,
0.21 to 0.84), 31% of
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improvement in
understanding, 41% for
enhanced consent form,
50% for extended
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Subgroup/metaregression analyses
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understanding: age,
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Rate of trial
participation has not
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trial availability,

Contribution:
Science and or
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communication skills
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needed for pts. to have
a comprehensive
understanding of IC
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structural, clinical, and
physician and patient
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clinical trial
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Juraskova, I.,Butow,
P., Bonner, C., Bell,
M. L., Smith, A. B.,
Seccombe, M., Boyle,
F., Reaby, L., Cuzick,
J., & Forbes, J. F.
(2014, p. 1-7).

for pts. In
community.

eligibility and
attitudinal. 3 out of 4
cancer pts. are not able
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Does a decision tool
help breast cancer pts.
make more informed
decisions to participate
in CCTs

146 pts. diagnosed
with breast cancer
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Needs to be
piloted in other
cancer patient
populations

Was the first RTC to
evaluated decision
aids in the CCT
setting.

The use of decisional
aids improves a
patient’s knowledge of
CCT understanding.
The control group had a
63.8% rate of objective
understanding while the
aid group had 77.7%
rate of objective
understanding
(P=0.008).

Bergenmar, M,
Johansson, Wilking,
N, Hatschek, T., &
Brandberg, Y. (2014,
p.1197-1204)
Audio-recorded
information to patients
considering
participation in cancer
clinical trials

Audio-recorded
information on
knowledge and
understanding in
patients considering
participation in a
clinical trial

Pts.
considering phases 2
or 3 trial
participation by 1
of 13 oncologists in
the dept from
2008–2013
(N =130) were
randomized

Level I B,
RCT

CCT IC
process
research is
needed

No subgroup
analyses & study
was underpowered

Levels of obj.
knowledge (< 50%)
regarding risks and
discomforts involved in
participation, the
unproven nature of the
trial, & confidentiality

Joffe, S., Cook, E.,
Cleary, P., Clark, J., &
Weeks, J. (2001, p.
1772-77)

Pts. actual and
perceived
understanding of
CCTs

Dana Farber Cancer
Institute
(n =3)
bioethicists
(n =3)
experts in CCTs
design
(n =207)

Level II A, Cross
sectional survey

Provides
future research
directions

Limited to cancer
setting

The QuIC, 20 questions
for objective
understanding and 14
for subjective
understanding & time
& ease of
administration & an
average of 7.2 minutes
to finish

Improving decision
making about clinical
trial participation

Quality of informed
consent in cancer
clinical trials
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modalities of learning
to have a holistic
understanding of
CCTs.

Improvements to
presentation of risks to
patients during IC are
needed

Pts. do not
comprehend elements
of IC

Glaser, J., Nouri, S.,
Fernandez, A., Sudore,
R., Schilinger, D.,
Klein-Fedyshin, M., &
Schenker, Y. (2020, p.
119-143)
Interventions to
improve patient
comprehension in
informed consent for
medical and surgical
procedures
Kass, N., Taylor,
Holly., Ali, J., Hallerz,
K., & Chaisson, L.
(2015, p.54-66)

Update to prior
systematic review &
studies publish of IC
interventions

(N =49)-RCTs, 3NRCTs from 20082018 & 60
interventions

Level II B,
Systematic
Review

Built on
previous
systematic
review

Variation in
interventions/outco
me measures

100% (8/8) of
interactive interventions
with test/feedback or
teach-back resulted in
improved patient
comprehension
compared to standard
IC practice

Test/feedback or
teach-back are better
when compared other
interventions

Feasibility testing of 2
IC interventions in
studies and measured
effectiveness

From 2009 to 2011,
(N =144)
participants
enrolling in 8
ongoing clinical
trials at JHSM and
JHSPH

Level II B, Pilot
study to
determine
feasibility and
effectiveness

Relevance and
transferability
of findings

Failure to randomize
which may lead to
bias or
contamination in
consent delivery and
data collection

Way to improved pt.
Understanding when
compared to standard
practice

Conceptualization and
item content of
validated patient
reported measures of
IC for clinical trials,
and to identify core
domains of potential
importance for IC

(N 14) articles, 179
items across 14
instruments

Level II C,
Systematic
review

Systematic
search &
rigorous
method

No formal
assessment of
interrater reliability,
No formal
assessment of the
methodological
quality of
instruments

Statistically significant
higher open- ended
scores were:: White
participants (z = 23.02,
p = .00), being
employed full time (p =
.03), having a higher
income (p = .00),
having a high reading
level (REALM level 4)
(p = .00, z = 23.99), and
receiving the consent
form in advance (z =
22.83, p = .00)
5 Core domains:
Autonomy,
Consequences,
Expectations, Purpose,
Individualism

A pilot study of simple
interventions to
improve informed
consent in clinical
research

Gillies, K., Duthie, A.,
Cotton, S., &
Campbell, M. (2018,
p. 1-20)
Patient reported
measures of informed
consent for clinical
trials
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Joffe, S, Cook, E,
Cleary, P & Weeks, J.
(2001, p. 381-402)

Design the Quality of
Informed Consent
(QuIC)

Dana Farber Cancer
Institute (N =32)
respondents was
selected, of whom
17 (53%) completed
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second time from
the original cohort
of survey
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Assess test–
retest reliability
of a crosssectional survey

Ensured
validity of
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Limited to cancer
setting

Ehrenberger, H., &
Lillington, L. (2004,
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Development of a
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the clinical trials
nursing role

Dimensions of the
CTN role & construct
a reliable and valid
survey instrument to
reflect these
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Judge panel 6
national nurse
executives, focus 24
CRNs from US, 5
CRNs from Canada,
sample Instrument
testing 40 CCTNs
from US
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Methodologic
Survey to
develop the
Clinical Trials
Nursing
Questionnaire
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Has content
validity,
internal
consistency,
stability
reliability

High item number in
survey could inflate
Cronbach’s alpha

Pentz, R., White, M.,
Harvey, D., Farmer,
Z., Liu, Y., Lewis, C.,
Dashevskaya, O.,
Owonikoko., T., &
Khuri, F. (2012,
p.4571-4578 )

Misunderstanding,
measured with careful
attention to recent
conceptual advances,
is as widespread as
feared, to identify the
characteristics of
participants who suffer
from TM or TMis , &
to search for
associations between
TM and TMis and TO

(N =95) participants
in phase 1 trials at a
single academic
institution

III A, Crosssectional survey
study

Conceptual
analyses for
TM and TMis

Results not
generalizable

Frequency and
importance of
activities within each
dimension of CRN
practice & provide

NIH Intramural
Campus in
Bethesda, Maryland,
RN and NP
Participants (N =

Level III A, Non
experimental,
cross-sectional
design using a

Large sample
size & results
are
generalizable,
internal

Small size serving
as RNC and even
fewer as an NPs

Quality of informed
consent

Therapeutic
Misconception,
Misestimation, and
Optimism in
Participants Enrolled
in Phase 1 Trials
Bevans et. al., (2012,
p. 421-427)
Defining clinical
research nursing
practice
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The QuIC, consists of
20 questions for
objective understanding
and 14 for subjective
understanding, tested
for time and ease of
administration and
required 7.2 minutes to
finish test–retest
reliability with
correlation co- efficient
of .66
Developed using a
mixed-method
approach and had high
content validity index
of 0.95, Cronbach’s
Alpha was 0.92 for the
frequency scale and
0.95 for the importance
scale
Sixty-five of 95 patients
(68.4%) had TM,
associated in a
multivariate analysis
with lower education
and family income (P
1⁄4 .008 and P 1⁄4 .001,
respectively

Most frequently cited
tool used in studies of
patient understanding

Results include: CRN,
has a significantly (p <
0.05) higher level of
activity frequency
within the CP

Important to improve
the IC process for
nurses and for patient
outcomes

First questionnaire
developed & used to
evaluate dimensions of
the CTN

TM is prevalent in
clinical trials

additional validation
of the proposed
conceptual framework
of the NIH Clinical
Center CRN domain
of practice

412) were
predominantly
female (90%) with
11 or more years of
research experience
(70%)

web-based
survey

validity is
strong

Describe pts
knowledge and
understanding of the
CCTs

March 2002February 2003

III, C

validated the
QuIC
questionnaire

small sample size

Krieger, J., Wackerly,
A., Krok-Schoen, J.,
Schoenberg, & Pasket,
E. (2015 p. 743-745).
Comprehension of
randomization and
uncertainty in cancer
clinical trials decision
making among rural,
Appalachian patients

Pt. comprehension of
the randomization
process and sources of
uncertainty

(N =49) patients
who were offered a
cancer treatment
with RCT within
the last 2 years and
lived in or were
treated for cancer in
1 of 32 Appalachian
Ohio counties

Level III B,
Semi-structured
interviews

Brings
awareness to
concerns of
rural cancer
patient
population

all types of cancers
and treatments and
could not be
generalized to
focused studies

Schumacher, A.,
Sikov, W.,
Quesenberry, M.,
Safran, H., Khurshid,
Mitchell, K., &

Understanding of
critical components of
IC of patients
enrolling in trials of
conventional or novel

Between June 2012
and Oct. 2014 , (N
=54) pts. at Brown
University

Level III B,
Prospective
observational
cross-sectional
study

Common
problem

Not sufficiently
powered & did not
evaluate the
contents of the ICFs

Barrett, R. (2005,
p.751-756).
Quality of Informed
Consent

(N =8) adult patients
in ambulatory
setting

Descriptive,
Correlational
study
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difficult to
generalize and
threatens external
validity

dimension (CRN M =
4.20 ± 0.84; RNC M =
3.43 ± 1.14) and
significantly lower level
of frequency in SM
(CRN M = 1.59 ± 0.75:
RNC M = 2.65 ± 0.77),
CCC (CRN M = 2.22 ±
0.91; RNC M = 3.46 ±
0.93), HSP (CRN M =
1.89 ± 0.89; RNC M =
2.53 ± 0.81), and CS
(CRN M = 1.30 ± 0.86;
RNC M = 1.98 ± 0.83)
Pt. perceptions
relationship between
knowledge of basic
elements of IC federal
regulations vs. using
physicians other than
their oncologists as
sources of information
(r =0.762, p =0.028)
High comprehension:
RCI score of 4 or 5 (n =
18; 39 %), Low
comprehension: RCI
score of 3 or lower
(n=28; 61 %)

Understanding with
education < than high
school diploma (mean,
64.3 ±10.4, compared
with 77.8±8.5 for high

Nurses can aid in the
IC practice and
improve patient
understanding

Concerns and
emotions about safety
of randomization must
be addressed during IC

IC is shaped by
regulatory and legal
polices, & pts. have

Olszewski, A. (2017,
p.29-57).
Informed consent in
oncology clinical trials
Hillyer, G.,
Beauchemin, M.,
Hershman, D., Kelsen,
M., Brogan, F.,
Sandoval, R., Schmitt,
K, Reyes, A., Terry,
M., Lassman, A., &
Schwartz, G. (2020,
p.184-194).
Discordant attitudes
and beliefs about
cancer clinical trial
participation between
physicians, research
staff, and cancer
patients
Cantini, F. & Ells, C.
(2007, p.126-144).
The role of the clinical
trial nurse (CTN) in
the informed consent
process
Nathe, J., & Krakow,
E. (2019)
The challenges of
informed consent in
high-stakes,
randomized oncology
trials

biologic/targeted
therapies & evaluated
how patient age, sex,
race, education level
or trial sponsorship
influence level of
understanding
Framework to assess
barriers to cancer
clinical trial
enrollment (CTE)

Current practice of
CTNs in the IC
process including the
role of CTN in IC PI is
a MD & conflicts of
interest and ethical
dilemmas by CTNs
during IC
Barriers to IC in highstakes CCTs and best
consent practices for
multi- stage RCTs

In 2017 -2018 at
Columbia
University Irving
Medical Center (N
=120)
physician/clinic-al
research staff
(39.2% MD/DO)
(60.8% staff), (N
=150) cancer
patients

Level III B,
Single site,
observational
study

First published
comprehensive
assessment
across
physicians,
staff, and
patients to
understand
differences in
CCT
perceptions

Did not include pts.
in development of
survey & limited
generalizability

(N =65) CTNS from
hospitals affiliated
with McGill
University in
Montreal, Quebec,
Canada.

III B,
Descriptive
study design &
Correlational
analysis

2 levels of data
were made

Poor external
validity & results
were not well
dispersed

From 1/1/1990 to
April 5, 2018 (N
=27) articles were
retained

Level III, B
Systematic
Review

Includes Alevel of
research

Results in narrative
form, no metaanalysis, & limited
search
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school diploma,
80.6±5.0 for associate
degree, 77.2 ±6.4 for
bachelor’s degree, and
79.2 ±10.0 for master’s
degree; ANOVA F =
3.7, P = .011)
Pts. reported negative
beliefs about CTE (e.g.
being in a trial does not
help patients
personally, 32.9% vs.
1.8%, p<0.001), pts.
less often felt they had
no other options when
agreeing to join (38.1%
vs. 85.6%, p<0.001),
pts. less often refused
CTE due to lack of
under-standing (9.1%
vs. 63.3%, p=0.001)
than reported by
MDs/staff
Ethical dilemmas :
Ethical training: Age (p
=-0.08), Years of
experience (p =-0.21),
Hours of training in
research ethics (p
=0.177)

little understanding of
research treatment

Variables that influence
understanding of the IC
form: Readability,
simplicity, length
quality, & stakes
involved

Pts. recruited to CCTs
may have
multivariable
problems related to IC

MDs/research staff do
not understand the
patient related barriers
to CCT participation

Need standardized and
mandatory training for
CTNs

Nusbaum, L.,
Neenah., EstrellaLuna
Orlow, M., &
Damus, K. (2019,
p.937-950)
Survey of risks and
benefits
communication
strategies by research
nurses

Attitudes and practices
of CRN and ways to
improve the IC
process

(N =107) CRNs in
US

Level III C,
Systematic
review for
survey questions

Database to
expand
knowledge on
attitudes,
training, and
practices
related to IC
process

Small sample size &
selection Bias,

(87%) of CRNS used a
teach-back method to
assess participant
comprehension, (33%)
not prepared to
communicate related
statistics, (20%) not
prepared to tailor
information, (50%) not
competent using
supplemental materials
to enhance risks and
benefits comprehension

Education and CRN
training should help to
improve and
standardize the ethical
IC process

Miller et al., (2013,
p.481-489)

Preparation for
consideration of an
CCT as a treatment
option mediates the
relationship between
knowledge, selfefficacy, and
decisional conflict & if
lower levels of
decisional conflict are
associated with greater
likelihood of CCT
enrollment
Evidence on using
teach-back method in
health education
programs for
improving adherence
and self-management
of people with chronic
diseases

(N=105) were at
least 18 years old
and had a cancer
diagnosis, and were
scheduled for their
initial consultation
with an oncologist at
the study site

Level III C, Prepost-test
intervention
study

First to report
on the
association of
self-efficacy
with decisional
conflict in an
CCT

Unable to assess
interrelations of
emotion, selfefficacy, and CCT
decisional conf

Decisional conflict was
reported as 26.29
(SD=19.28)
-This result reinforces
previous findings that
knowledge alone is not
sufficiently potent to
reduce conflict, even
when pts. feel prepared

Educational
intervention to impact
knowledge, selfefficacy, preparation
and decisional conflict
is needed

(N=10) studies on
the use of teachback, 8RCT/NRCTs, 1cohort, 1before/after

Level III C,
Systematic
review

First
systematic
review of
teach-back
described in
English
literature

No meta-analysis &
results are in
narrative from

Positive effects in
outcomes (p < 0.001),
statistically significant
improvements in selfefficacy (p = 0.0026
and p < 0.001) in the
intervention groups

Does not require
literacy, allows pts.
with low literacy
levels to actively
participate and for
reinforcement of
information during
appointments

The relationships
among knowledge,
self-efficacy,
preparedness,
decisional conflict,
and decisions to
participate in a cancer
clinical trial
Dinh, H., Bonner, A.,
Clark, R.,
Ramsbotham, J., &
Hines, S. (2016,
p.210-247).
The effectiveness of
the teach-back method
on adherence and selfmanagement in health
education for people
with chronic disease

Prioritizes
disadvantaged people
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Godskesen, T., &
Nygren, P., & Nordin,
K., & Hansson, M.,
& Kihlbom, U. (2013,
p. 3137-3142)
Phase 1 clinical trials
in end-stage cancer:
patient understanding
of trial premises and
motives for
participation
Kao, C., Aranda, S.,
Krishanasamy, M., &
Hamilton, B. (2017,
p.1-13)
Interventions to
improve patient
understanding of
cancer clinical trial
participation
Forbes, S. G., &
Phillips, C. A. (2020,
p.428-436)
Ethical challenges
encountered by
clinical trials nurses
Cresswell, P., &
Gilmour, J.,
(2014, p.17-28).

Difficult ethical
problems related to
patient information
and motives for
participation in trials

Interventions to
improve patient
understanding of OCT
participation

Ethical challenges
experienced by
CCTNs during the
management of
clinical trials and
examine how they
resolve those conflicts
The CRN in the IC
process in-depth

The informed consent
process in randomized
controlled trials
Talevski, J., Shee, A.,
Bodil Rasmussen, G.,
Kemp, A.,

Synthesize evidence
about the translation of
teach-back into

14 cancer patients
from three different
phase 1 trials in endstage cancer

III C,
Descriptive/
explorative
qualitative study

Sociopsychological
aspects
powerful

Small Sample Size,
may lead to bias, &
not generalizable

unrealistic expectations
of therapeutic benefit
and inadequate
understanding of the
trials’ purpose, socalled therapeutic
misconception

Pts. unaware of small
potential for treatment
benefit and risks for
har
Offers hope, social,
& emotional support

(N =9), pre-post-test
(1), case–control
(1), or RCTs (7),
Adults with cancer,
participating in
drug-related clinical
trials (N =1368)
(phase I, II or III)
between 2000 and
2013
(N =12) licensed
RNs who have been
CCTNs two years or
more at US
academic medical
centers in the US

Level III C,
Systematic
Review

Guides future
research

Lacked reliable and
valid outcome
measures

Teach-back
Interventions may
improve patient
satisfaction of the IC
process

Level of comfort with
the decision made or
decisional regret
indicate success of IC
interventions

Level III C,
Qualitative
survey study,
CGT data
extrapolation and
analysis

Provides
framework for
CCTNs

Study sample size,
selection bias, data
collection method
limited
generalizability

CGT data analysis
revealed the CCTNs’
main concern was
implementing an
undefined job

Novice CCTNs need
basic knowledge and
skills to fulfill
responsibilities of new
role

(N =3) CRNs with
post-graduate
degrees in an
academic cancer
institute in New
Zealand in April of
2012

Level III C,
Qualitative
descriptive study

Contributes to
CRN role
understanding

small sample size &
not generalizable

3 themes were
identified in gaining
informed consent,
preparatory, partnership
with participants, &
partnership with the
project

IC can be led by CRNs
who use teach-back

(N =20) studies of
moderate quality , (n
=4) rated high, (n

Level III C,
Systematic
review

First
systematic
review

No assessment of
implementation

(n = 15), teach-back
was delivered as a
structured educational

Teach-back is
effective , no studies
adapted teach-back
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Beauchamp, D. (2020,
p.)
Teach-back: A
systematic review of
implementation and
impacts

practice including
mode of delivery, use
of implementation
strategies, and
effectiveness

=9) rated moderate ,
(n =7) rated weak

Lentz, J., Kennett, M.,
Perlmutter, J., Forrest,
A. (2016, p.65-69).

Problems in the
current IC process and
to formulate
recommendations for
improvement

In 2014, Clinical
Trials
Transformation
Initiative (CTTI)
project, expert
interviews, & expert
meeting from a
diverse (FDA) and,
academic
Literature review of
key elements of
clinical trials in drug
approval

Paving the way to a
more effective
informed consent
process
Kurtin, S. E., & Taher,
R. (2020, P. 736–751).
Clinical trial design
and drug Approval in
oncology: A primer
for the advanced
practitioner in
oncology.

EBP requires
appropriate and welltimed incorporation of
scientific discoveries

appraising the
translation of
teach-back
into practice

fidelity & no metaanalysis

Level IV A,
Literature
review,
telephone expert
interviews,
multistakeholder
meeting

Implementatio
n of new
processes in
clinical
research is
challenging

Pt. at forefront of
considerations
related to IC

Level IV A,
Literature review

All currently
FDA cancer
treatments
originated
from clinical
trials

Must understand
clinical trial process
to adequately
perform IC
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approach,
Implementation
strategies were
infrequently reported (n
= 10), implementation
strategies: training and
education of
stakeholders (n = 8),
support for clinicians (n
= 6) and use of audits
and provider feedback
(n = 4), Use of teachback was 19 of the 20
studies, learning-related
outcomes to objective
health-related outcomes
4 topics were
foundation of
recommendations

intervention to the
specific patient
population

Elements include:
Phases of and primary
objectives of trials,
hierarchy of clinical
data, endpoints, adverse
event attribution, and
common graphs and
diagrams

Familiarity with
clinical trial
definitions is
imperative to effective
conduct and report of
trials

Can be used as a tool
for my DNP project

Oncology Nursing
Society (2016, P. 120).
2016 Oncology
Clinical Trials Nurse
Competencies
Fidyk, L., Ventura, K.,
& Green, K. (2014)
Teaching nurses how
to teach

Herena, P. Paguio,F.
& Pulone, C. (2018,
p.450-452)
Clinical Research
Nurse Education

Showalter, E., Cline,
M., Yungclas, A.,
Frentz, P., Stafford,
K., & Maresh, M.
(2017, p. 633-636).
Clinical Research
Nursing
Regan, E. (2018, p.
E152-E158).
Clinical Trials
Informed Consent: An
educational
intervention to
improve nurses’

Ensure that 2016
competencies reflect
the current clinical
trials and CCTN
competencies

Revision,
competency
development, expert
review panel, field
review

Level IV, A
Model and
framework

Development of a
training course for
nurses that focused on
teach-back as a
strategy to improve
patient education and
understanding

(N =15) clinical
nurses from
inpatient and
outpatient settings
completed a piloteducation course

Level V, A, QIP
& Expert opinion

Catalyst for a
formalized and
standardized
system wide
recurring
course offered
to nurses

Difficult to measure
what types of patient
education
interventions are
most effective

Experience at an NCIdesignated
comprehensive cancer
center which adopted a
CRN education
program due to a high
percentage of CRN
turnover
Development and
content of a research
nurse residency
program

(N =48) CRNs at a
large academic NCICCC have
completed the
course

Level V, A, QIP
& expert opinion

Can be
generalized to
other CRNs
around the
country

Results reported
early & follow up
results could have a
larger
impact/implication
of the necessity of
intervention

12-months program
for new graduates
initiated in May
2016, and has had 3
cohorts, (N =24)
CRNS in total at an
NCI-CCC in Texas.
Dana-Farber Cancer
Institute

Level V, A, QIP
& expert opinion

Novel
approach &
provides
structure and
framework to
implement

May not be
replicable in smaller
institutions

Adapted for
local practice
or introduced
to CCTNs in
training
programs

May not be
generalizable &
small sample size

Educational program
for nurses to improve
knowledge and
communication skills
used in IC for CCTs

(N =26), 22 CRNs,
4 NPs

Generalizable

Level V, A, QI
Convenience
sample,
educational
program
pre-, & post-,
paper surveys
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Field review was
conducted through
ONS members only

CCTN model and
framework includes
behaviors and
competencies required
to coordinate clinical
trials and manage
research patients
Pre/Post Course
evaluation using a 4point Likert scale
survey immediately
after & 3 months post
course. Improvements
with assessing health
literacy and better
patient education
implemented Turnover
rate dropped to 5.9%,48
30 of the 48 attendees
showed increase in
knowledge across 4
domains

Experts from ANA &
IACRN

ORNR has shown that
it can provide a
sustainable educational
infrastructure

CRNs are essential in
the coordination of
clinical trials and the
management of
oncology research

important role of a
CRN: Response
categories included;
patient education (n =
16), patient advocacy
and navigation (n = 8),
monitoring toxicity (n =
4), and confirmation of
eligibility and In-

Teach-back is a an
evidenced-based
method

Must have
leadership support

is a newly
developed tool with
evidence of prior

Organizations should
develop indicators to
measure competencies
Sustainable and can be
standardized

Staff shortages of
CRNs leaves few with
the necessary skill set
to cover the jobs of
many

knowledge and
communication skills

Anderson, K., Leister,
M., De Rego, R.
(2020, p. 94-103).

Always use teachback! Toolkit.
Agency for Healthcare
Research and Quality.
(2020).
Health Literacy
Universal Precautions
Toolkit

Shoemaker, S, &
Brach, C. (2017).

use only by original
authors
QuIC-B, designed
for patients, required
modification
Do not retain
knowledge of the
5Ts after a single
Teach-Back training
session

Training program with
observable
components

(N =1300) HCWs in
a large academic
health care system

Level V A,
Single 4-hour
training &
comprehensive
training program

Can be used
for training,
coaching, and
evaluation

Effective oral
communication
strategies and offer
suggestions on how to
increase staff
awareness as they
interact with patients
Reduce the complexity
of health care, increase
patient understanding
of health information,
and enhance support
for patients

NA, guidelines

Level V B,
Recommenddations and
guidelines

Clear on how
to implement
into practice

NA, guidelines

Level V B,
Recommenddations and
guidelines

Implementing the
AHRQ’s training
modules for healthcare

NA, guidelines

Level V, B

The 5Ts for Teach
Back

Abrams, M., Rita, S.,
Klurz-Rossi., &
Nielsen, G. (2012).

and one-month
post-program
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formed Consent (n = 2).
QuIC-B mean score
was 61% (SD = 15.96)

Operationalizes the
definition of Teach
Back & provides model
for training related to
the 5-Ts:Take
Responsibility, Tell
me, Triage, Tools, and
Try Again

Teach Back
competence increases
with reinforcement

New process
implementation in
clinical research is
challenging

Teach-back is a test of
how well you explained
the concept & ensure
clear communication

Effective
communication with
pts. ensures safety,
self-management, &
efficient time

Clear on how
to implement
into practice

New process
implementation in
clinical research is
challenging

Clinicians should
simplify
communication for all
pts.

How leaders
and clinicians
implement

New process
implementation in

21 Tools that help
improve
communication, written
communication, selfmanagement and
empowerment, &
supportive systems &
25 resources such as
sample forms,
PowerPoint
presentations, and
worksheets & Quick
Start Guide
Improved IC and
policies and practice in
4 hospital systems, QI
approach in sequential

Improve pt. safety,
decrease liability
issues, increase
patient-centered care,

Implementation guide
for Agency for
Healthcare Research
and Quality’s making
informed consent an
informed choice
training module. #3.
Speros, C. I. (2011, p.
321-333).
Promoting health
literacy

professionals and
healthcare leaders

Define health literacy
and provide ways to
promote it

NA, expert opinion

Recommenddations and
guidelines

practice
change

clinical research is
often challenging

and sustainable steps &
importance of guideline
implementation

and decrease financial
loses

Level V, B
Recommendations and
guidelines

Clear on how
to implement
into practice

New process
implementation in
clinical research is
often challenging

Influenced by
individual, cultural,
social, and political
factors

Fundamental to
informed decisionmaking
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Appendix C : Kurt Lewin’s Change Management Model Adaptation for this DNP Project

Unfreezing

Moving

Refreezing

Examine status quo and

Take action, make changes,

Make changes permanent,

increase driving forces for

and involve people.

establish new way of
things, and reward desired

change.

outcomes.
The first stage in Lewin’s
Change Management Model
(1947) is Unfreezing, which
began when the project author
recognized the need for nurses
to have a standardized process
of consent in oncology clinical
trials. When questioned, many
members of the International
Association of Clinical Research
Nurses reported no standardized
method for their consenting
practices, no formalized trainings
on the topic, and low confidence
with the process. A stakeholder
analysis of the professional
organization was conducted
which revealed the need for a
project which increases
educational opportunities for its
nurses

The second stage in Lewin’s
Change Management Model
(1947) is Move which is when
the construction and
implementation of the DNP
project commences with the
implementation an education
program. In this stage, nurses
may resolve their uncertainty
about the need for change of
informed consent processes
and accept new ways of
practice.
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The third stage in Lewin’s
Change Management Model
(1947) is Refreeze. If the
project is successful, the
nurses will have more
confidence with use of teachback and will use the method
when performing informed
consent in oncology clinical
trials. Furthermore, this
education program could
become part of a training
session that International
Association of Clinical
Research Nurses offers on a
consistent basis.

Appendix D: SWOT Analysis

Strengths

Weaknesses

Abundant teach-back resources available for use,
learning opportunities for nurses

Exclusivity of the education program to
International Association of Clinical Research
Nurses members only and may reduce the
amount of nurses who participate in the program

The project is congruent with the vision and
mission of the International Association of
Clinical Research Nurses
The project operationalizes Good Clinical
Practice by nurses, as it will reinforce how to
skillfully communicate alternative treatments to
the proposed oncology clinical trials, as well as
the relevant risks, benefits, and uncertainties of
participation to patients

Some nurses who attend may not practice in the
oncology specialty as International Association
of Clinical Research Nurses is open to all fields
of medicine
The event will be virtual and this may make it
more difficult for the project author to develop a
meaningful connection with the attendees

This project empowers nurses to proficiently
identify components of the informed consent
process for which patients need assistance in
understanding and allows patients to clarify
misconceptions in real-time
Opportunities

This program will only be advertised through
IACRN online and virtual platforms

The project may increase nurse confidence with
use of the teach-back method when performing
informed consent in oncology clinical trials

No one may attend the virtual event

This education program could become part of a
training session offered by IACRN on a
consistent basis

Despite training, nurses may refuse to use teachback in their consent practices

This education program could be replicated at the
project author’s workplace and in similar
oncology clinical trial settings

Threats

This program will only be presented once

Nurses may miss the opportunity to attend the
education program due to prior commitments, or
time constraints related to their current workload
Nurses may be unaware of the opportunity
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Appendix E: Teaching Plan for Education Program
Methods:
Time allowance for presentation: One hour
Question and answer session: 30 minutes
Education program objectives:
At the end of the presentation and question and answer session, the oncology clinical trial
nurses will be able to do the following:
Identify factors that influence patient understanding and promote learning
Define health literacy
Understand and describe steps of the teach-back method
Describe the role and value of the teach-back method
Identify strategies to facilitate the use of teach-back into your cancer clinical trial consenting
processes
Education Program Content
Factors that influence patient teaching include not giving patients the opportunity to ask
questions, timing of education presentation, no confirmation of comprehension or little follow up
(AHRQ, 2020). Ways to promote health literacy include creating a shame free environment,
using clear, purposeful, and patient centered communication, and reinforcing and verifying what
was taught (Speros, 2011). The Institute of Medicine (2010) defines Health Literacy as: “The
degree to which individuals have the capacity to obtain, process, and understand basic health
information and services needed to make appropriate health decisions. Health literacy is
influenced by individual, cultural, social, and political factors and is fundamental to informed
decision-making (Tam et al., 2015; Speros, 2011). Effective communication positively correlates
with better patient adherence.
The Agency for Healthcare Research and Quality (2020) defines teach-back as a
“communication method used in a respectful way to provide real-time assessment which
confirms patient understanding of the complex health related concepts that you tell them
(Anderson et al., 2020; Regan, 2018; Dinh et al., 2016; AHRQ, 2020; Nusbaum et al., 2019).
The teach-back method helps patients remember and understand more information, raises their
satisfaction, helps them feel more relaxed, and helps clinicians garner their patients’ trust
(Abrams, 2012; AHRQ, 2020). The principles of the teach-back method and 10 observable
elements on which it is based remind the nurse to choose the pertinent information for the patient
to retain and comprehend, use tools to provide explanations when teaching, verbalize that
material presented to the patient is abstruse and that the nurse is the one being tested for how
well the concepts were explained, encourage the patient to give an explanation of concepts in
their own words, and repeat concepts if the patient does not fully comprehend (Abrams, 2012;
AHRQ, 2020; Anderson et al., 2020). An observation tool called “the 5Ts for Teach-Back,”
proved useful for training, and coaching of teach-back implementation in the clinical setting
(Anderson et al., 2020). The Teach-back Observational tool may serve as a script for
remembering the 10 elements during the informed consent visit and help to facilitate the use of
the teach-back method into practice (Abrams 2012; Anderson et al., 2020; AHRQ 2020).
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Some patients perceive clinical trial participation as personal medical care instead of
research and are unaware that alternative treatments exist (Pentz et al., 2012; Schumacher et., al,
2017). For patients diagnosed with cancer, teach-back decreases uncertainty related to
randomization, significantly improves comprehension of disease knowledge (p < 0.001),
medication adherence (p < 0.001), and self-efficacy (p = 0.0026) [Dinh, et al., 2016; Krieger, et
al., 2015]. Other factors that contribute to a patient’s level of CCT understanding include
innovations in clinical trial design, changes in the setting of clinical research delivery for
biomedical interventions, first in human studies, an increasing number of procedures per
protocol, readability, and length of consent forms (Getz & Campo, 2018; Nathe & Krakow,
2019). Teach-back is an effective method available for use by nurses to communicate complex
oncology clinical trial-specific information to patients during the consent process (Lentz et al.,
2014; AHRQ, 2020; Speros, 2011). The teach-back method helps nurses facilitate the process
and helps them consider the patients’ psychosocial situation, family support, and appropriate
timing of consent (Nusbaum et al., 2019). Extended contact with healthcare professionals and
discussion with a question and answer sessions significantly increase comprehension of a
patient’s treatment options, the risks and discomforts associated with participation, the research
design, and the unproven nature of the trial (Bergenmar et al., 2014; Kass et al., 2015; Nishimura
et al., 2013). Patient understanding of IC mediates the relationship between a patient’s selfefficacy and decisional conflict to participate in CCTs (p=0.003) [Dinh et al., 2016; Miller et al.,
2013; Tam et al., 2015]. When tested in four studies, interactive interventions used during
consent with teach-back or test/feedback components improved patient comprehension by 100%
when compared to standard practices (Glaser et al., 2020).
Knowledge Checks
Question One: What is the most important rationale for using teach-back during the
oncology clinical trial informed consent process?
a. To test the patient on his/her ability to repeat the important health information given
b. To give the patient time and opportunity to talk to you
c. To alert you to whether or not your communication was clear
d. To meet all informed consent requirements
Correct answer: C, Teach-back serves as a check to see how well the patient understood
what the clinician told him or her.
Question Two: Factors that promote patient teaching are all of the following expect:
a. Timing of education presentation.
b. Social and cultural factors.
c. Not giving your patient the opportunity to ask questions.
d. No confirmation of comprehension.
Correct Answer: B, factors that promote patient teaching are use clear purposeful
communication, communicate in a patient centered manner, create a shame free
environment, reinforce the spoken word, and verify understanding.
Question Three: Which are examples of open ended questions or inferences which
encourage discussion and assess comprehension?
a. Please explain to me what the doctor said you would need to do while you are on the
clinical trial.
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b. Tell me in your own words the purpose of the clinical trial.
c. What more would you like to know about the clinical trial?
d. What is the possible benefit to you of participating in this study?
e. What are the possible risks?
f. How often you will need to come to visit us in the clinic?
Correct Answer: All of the above, Open ended questions encourage discussion and assess
comprehension.
Case Study Discussion
A patient newly diagnosed with bladder cancer presents to your clinic for a second opinion and
treatment options. The medical oncologist has informed the patient that the pathology from her
biopsy was confirmed as bladder cancer by your team of pathologists. The medical oncologist
recommends a clinical trial as her treatment option. Once finished with his discussion, the
medical oncologist requests that you speak to the patient more about the clinical trial and review
the consent form with them. You introduce yourself to the patient as the oncology clinical trial
nurse. Immediately, the patient asks, “Is this clinical trial a safe treatment option? ”How do you
respond? And what elements of teach-back can you use to help the patient have a better
understanding of oncology clinical trials?
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Appendix F: Education Program PowerPoint Presentation
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Appendix G: Permission to AHRQ Teach-back Toolkit
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Appendix H: Permission for implementation
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Appendix I: Participation Emails

65

Appendix J: Teach-back Observation Tool

Reprinted fromwww.IHI.org with permission of the Institute for Healthcare Improvement (IHI),
© 2011
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Appendix K: Conviction and Confidence Scale Survey

Reprinted fromwww.IHI.org with permission of the Institute for Healthcare Improvement (IHI),
© 2011
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Appendix L: Pre and Post Program Surveys accessed through Qualtrics Hyperlink
Use of Teach-Back During Informed Consent in Cancer Clinical Trials
Q1 Please choose your age range:
o 18 to 25
o 26-35
o 36-45
o 46-55
o 56+
Q2 Highest Degree? Please provide type of degree
o Associates (1) ________________________________________________
o Bachelors (2) ________________________________________________
o Masters (3) ________________________________________________
o Doctoral (4) ________________________________________________
Q3 Years experience in a clinical trial setting?
o Less than 1
o 1-2
o 3-4
o 5-6
o 7+
Q4 Have you ever had formalized training on how to perform informed consent in cancer
clinical trials?
o No
o Yes
Q5 On a scale from 1 to 10, how convinced are you that it is important to use teach-back
(ask patients to explain key information back in their own words)? 1- Not at all important,
10- Very important
Q6 On a scale from 1 to 10, how confident are you in your ability to use teach-back (ask
patients to explain key information back in their own words)? 1- Not at all confident, 10Very confident
Q7 How often do you ask patients to explain back, in their own words, what they need to
know or do to take care of themselves?
o I have been doing this for 6 months or more.
o I have been doing this for less than 6 months.
o I do not do it now, but plan to do this in the next month.
o I do not do it now, but plan to do this in the next 2 to 6 months.
o I do not do it now and do not plan to do this.
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Q8 Check all the elements of effective teach-back you have used more than half the time in
the past work week.
o Use a caring voice and attitude.
o Display comfortable body language, make eye contact, and sit down.
o Use plain language.
o Ask the patient to explain, in their own words, what they were told.
o Use non-shaming, open-ended questions.
o Avoid asking questions that can be answered with a yes or no.
o Take responsibility for making sure you were clear.
o Explain and check again if the patient is unable to teach back.
o Use reader-friendly print materials to support learning.
o Document use of and patient’s response to teach-back.
o Include family members/caregivers if they were present.
o and attitude.
o Display comfortable body language, make eye contact, and sit down.
o Use plain language.
o Ask the patient to explain, in their own words, what they were told.
o Use non-shaming, open-ended questions.
o Avoid asking questions that can be answered with a yes or no.
o Take responsibility for making sure you were clear.
o Explain and check again if the patient is unable to teach back.
o Use reader-friendly print materials to support learning.
o Document use of and patient’s response to teach-back.
o Include family members/caregivers if they were prese
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Appendix M: Stakeholder Analysis
Name

Title/Role

Christa
Varnadoe,
MSN, AGNP-C,
OCN

Operational/Project
Leader, Assistant
Director, Solid
Tumor Oncology
Research, Tish
Cancer Institute
Project Sponsor,
Internal Academic
Advisor, Yale
School of Nursing,
Co-Chair PhD
Program
Project Sponsor,
External Academic
Advisor, Senior
Director for
Oncology Nursing
and Clinical
Quality Mount
Sinai Hospital
External Advisor,
Nurse Manager,
Office of Human
Research Services
at Rutgers Cancer
Institute

Dr. Tish Knobf,
PhD, RN,
FAAN

Dr. Toby
Bressler, PhD,
RN, OCN,
FAAN

Andrea
Gonzales, MSN,
RN

Kelly Gleason,
MSc, BSN,
OCN

External Advisor,
Co-founder and
Director at
Clinfield,
Cambridge UK

Catherine
Director &
Griffith, PhD,
Founder,
ANP-BC, FAAN Massachusetts
General Hospital
CRN
Collaborative,
Chair- IACRN

Characteristics/
Interest

Project
Estimated
Engagement Priority

Potential
Management
Strategies
Networking will all
involved in the
project.

Role of CCTNs
& Improving IC
Process
High

Leadership

1

Provide expert
guidance and
clarity for project
logistics and
feasibility
High
Provide expert
guidance and
clarity for project
logistics and
feasibility
High

Leadership

1

Monthly updates on
project planning &
progress.

Leadership

1

Monthly updates on
project planning &
progress.

Increasing
opportunities for
research nurses to
grow in their
profession and
standardizing
CCT IC processes
High
Seasoned clinical
research nurses
with international
experience and
connections
High
Key member of
IACRN and will
promote project to
professional
organization
Low

Supportive

2

Weekly updates and
participation in
project planning

Supportive

2

As needed
consultations

Supportive

2

Quarterly updates on
project development
& progress
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Elizabeth Ness,
MS, BSN, RN,
CCRP

Clinical Trial
Nurses

Research
Committee
Director, Office of
Education and
Compliance, NCI,
Center for Cancer
Research, Coauthor Scope and
Standards for
CRNS
Members of the
International
Association of
Clinical Research
Nurses

Key member of
IACRN Education
Committee, and
will promote
project to
professional
organization
Low
Will need their
participation in
the education
program for
project to be
successfully
implemented
High
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Supportive

2

Quarterly updates on
project development
& progress
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1

Monthly updates on
project development
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Weekly zoom
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